Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MSL
5151
DELISTED
Midsouth Bancorp, Inc.
MSL
| $250K | ﹤0.01% |
20,711
+2,182
| +12% | +$25.5K |
2013 Q2
17 quarters
|
|
|
NYV
5152
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
| $249K | ﹤0.01% |
16,852
+537
| +3% | +$8.16K |
2013 Q2
17 quarters
|
|
5153
DELISTED
Old Point Financial
OPOF
| $248K | ﹤0.01% |
7,639
+2,659
| +53% | +$84.3K |
2013 Q4
15 quarters
|
|
|
GST
5154
DELISTED
Gastar Exploration Inc.
GST
| $248K | ﹤0.01% |
282,701
+67,665
| +31% | +$50.4K |
2013 Q2
17 quarters
|
|
5155
Anavex Life Sciences
AVXL
$121M
| $247K | ﹤0.01% |
59,925
+4,640
| +8% | +$20.6K |
2015 Q4
7 quarters
|
|
5156
OneMain Financial
OMF
$6.44B
| $247K | ﹤0.01% |
8,775
-9,831
| -53% | -$263K |
2013 Q4
15 quarters
|
|
|
PKD
5157
DELISTED
Parker Drilling Company
PKD
| $247K | ﹤0.01% |
15,019
+1,513
| +11% | +$27.6K |
2013 Q2
17 quarters
|
|
|
CASC
5158
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $247K | ﹤0.01% |
60,383
+14,581
| +32% | +$55.8K |
2013 Q2
17 quarters
|
|
|
SPNE
5159
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $246K | ﹤0.01% |
21,860
+9,286
| +74% | +$107K |
2015 Q3
8 quarters
|
|
|
AGTC
5160
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $246K | ﹤0.01% |
62,226
-72,900
| -54% | -$335K |
2014 Q2
13 quarters
|
|
|
DSUM
5161
DELISTED
Invesco Chinese Yuan Dim Sum Bond ETF
DSUM
| $246K | ﹤0.01% |
10,568
+2,739
| +35% | +$63.4K |
2013 Q2
17 quarters
|
|
5162
ProShares UltraShort MSCI Brazil Capped
BZQ
$2M
| $242K | ﹤0.01% |
326
+213
| +188% | +$183K |
2015 Q3
8 quarters
|
|
|
JNP
5163
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $242K | ﹤0.01% |
53,156
-23,945
| -31% | -$112K |
2013 Q3
16 quarters
|
|
5164
Chunghwa Telecom
CHT
$37B
| $241K | ﹤0.01% |
7,078
+409
| +6% | +$14.1K |
2013 Q2
17 quarters
|
|
5165
DELISTED
Middlefield Banc Corp
MBCN
| $241K | ﹤0.01% |
10,432
+5,342
| +105% | +$123K |
2014 Q4
11 quarters
|
|
5166
Willis Lease Finance
WLFC
$795M
| $241K | ﹤0.01% |
29,349
-5,295
| -15% | -$43.7K |
2016 Q1
6 quarters
|
|
|
ECYT
5167
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $241K | ﹤0.01% |
170,576
-369,409
| -68% | -$515K |
2013 Q2
17 quarters
|
|
|
FXS
5168
DELISTED
Invesco CurrencyShares Swedish Krona Trust
FXS
| $241K | ﹤0.01% |
2,058
-245
| -11% | -$28.9K |
2013 Q2
17 quarters
|
|
5169
ACNB Corp
ACNB
$644M
| $240K | ﹤0.01% |
8,660
+2,353
| +37% | +$65.5K |
2013 Q4
15 quarters
|
|
|
CSTR
5170
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $240K | ﹤0.01% |
12,264
+371
| +3% | +$6.54K |
2016 Q3
4 quarters
|
|
5171
KALA BIO
KALA
$3.67M
| $239K | ﹤0.01% |
+4
| New | +$219K |
2017 Q3
0 quarters
|
|
5172
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $239K | ﹤0.01% |
18,038
-534
| -3% | -$6.63K |
2013 Q2
17 quarters
|
|
|
PUW
5173
DELISTED
Invesco WilderHill Progressive Energy ETF
PUW
| $239K | ﹤0.01% |
9,015
-91
| -1% | -$2.3K |
2013 Q2
17 quarters
|
|
5174
DELISTED
Mr. Cooper
COOP
| $238K | ﹤0.01% |
20,880
+5,621
| +37% | +$78.9K |
2015 Q3
8 quarters
|
|
5175
Global Water Resources
GWRS
$230M
| $238K | ﹤0.01% |
25,311
+12,689
| +101% | +$122K |
2016 Q2
5 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.